DATROWAY (datopotamab deruxtecan-dlnk) for injection
DATROWAY is used to treat specific types of advanced or spreading breast cancer and non-small-cell lung cancer (NSCLC). FDA approved datopotamab deruxtecan-dlnk (brand name DATROWAY) is not (yet) registered or available in India. The access to the drug is provided as per Name Patient Program respecting the regulatory framework as desired by local authorities.
Home | datopotamab deruxtecan-dlnk for Injecion
Submit a request to access drug used to treat, diagnose or prevent serious or life-threatening conditions.We’ll get back to you within 1 business days!
For Indian Patient Enquiry under NPP.
For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.